Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms
Pilot Study to Evaluate the Effects of the Nanohealth, Inc. Cooling Bolero in Women With Common Menopause Symptoms
1 other identifier
interventional
15
1 country
1
Brief Summary
The Cooling Bolero is a a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat. The vest is manufactured by Nanohealth. It intended to provide moderate cooling (\~15C/59F) through indirect contact with the skin. The material in the device is safe, non-toxic, and eco-friendly. Recent anecdotal studies of women with common peri-menopausal and menopausal symptoms (hot flashes, night sweats, flushing/sweating of face and neck, and intermittent sleep disturbances) have shown a reduction in both the frequency and intensity of those symptoms after using the Cooling Bolero. Specific (moderate) temperature cooling of the neck and upper torso appears to target and mitigate these common menopausal symptoms. This pilot study attempts to collect additional data on the effects of the Cooling Bolero.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 10, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedJune 14, 2018
June 1, 2018
1.7 years
June 2, 2016
June 13, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with a reduction in the frequency and/or intensity of menopause symptoms
Diaries will be used to capture data pre-intervention, during the intervention, and post-intervention
one month
Study Arms (1)
Cooling Bolero
EXPERIMENTALAll participants will use the Cooling Bolero for one month
Interventions
a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat
Eligibility Criteria
You may qualify if:
- Female, who is at least 18 years old.
- Self-reports having at least two (2) daily hot flashes associated with menopause.
You may not qualify if:
- Has another existing medical condition that would prevent study compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Englewood Hospital and Medical Centerlead
- Nanohealth, Inc.collaborator
Study Sites (1)
Englewood Hospital and Medical Center
Englewood, New Jersey, 07631, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
David Abramson, MD
Englewood Hospital and Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2016
First Posted
June 10, 2016
Study Start
July 1, 2016
Primary Completion
March 1, 2018
Study Completion
May 1, 2018
Last Updated
June 14, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share